Induction of apoptosis by 2-chlorodeoxyadenosine in B cell chronic lymphocytic leukemia.
We investigated whether 2-chlorodexoyadenosine could induce apoptosis in B cell chronic lymphocytic leukemia (B-CLL) cells in vitro using clinically achievable drug doses, measuring apoptosis ratio by flow cytometry. B cells were isolated from previously untreated patients and apoptosis was measured in these cells immediately after isolation and following incubation in vitro, without and with 2-chlorodeoxyadenosine at different concentrations, for 24 and 48 h. Distribution of cellular DNA content and quantitative analysis of apoptosis were determined by standard propidium iodide staining and flow cytometry. Spontaneous apoptosis occurred in B-CLL cells incubated in vitro in the absence of drug, but the level of apoptosis was greater in cells treated with 2-chlorodeoxyadenosine after the second day of culture. The present in vitro study of B-CLL cells from previously untreated patients suggests this chemotherapeutic agent activates a program of cell death by apoptosis using a drug dose equivalent to the physiological concentration used in patients in vivo. These data reveal an interesting possibility in the 2-chlorodeoxyadenosine treatment of untreated patients by neoplastic B cell apoptosis induction.
Castejón
R
R
Service of Internal Medicine I, Clinica Puerta de Hierro, Universidad Autónoma, Madrid, Spain.
Vargas
J A
JA
Briz
M
M
Berrocal
E
E
Romero
Y
Y
Gea-Banacloche
J C
JC
Fernández
M N
MN
Durantez
A
A
D000328:Adult; D000368:Aged; D017209:Apoptosis / Q000187:drug effects*; D017338:Cladribine / Q000494:pharmacology*; D053938:DNA Fragmentation / Q000187:drug effects; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm; D017338:Cladribine